Now showing items 1-1 of 1

    • Substandard rifampicin based anti-tuberculosis drugs common in Ugandan drug market 

      Ocan, Moses; Vudriko, Patrick; Ntale, Muhammad; Ogwal-Okeng, Jasper; Obua, Celestino (Journal Of Pharmacy And Pharmacological Research, 2013)
      Background: Tuberculosis (TB) is an important curable infectious disease in Uganda; its treatment however is facing a challenge of increasing drug resistance. Although Rifampicin containing Fixed-Dose Combination (R-FDC) ...